| Name | CD4 |
|---|---|
| Synonyms | CD4; CD4 antigen (p55); CD4 molecule; CD4mut; T cell antigen T4/LEU3; T cell surface glycoprotein CD4; T cell surface antigen T4/Leu 3; T cell surface glycoprotein CD4 precursor… |
| Name | sulfoxide |
|---|---|
| CAS | 5-[2-(octylsulfinyl)propyl]-1,3-benzodioxole |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 17603023 | Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D: Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity. Biochem Pharmacol. 2007 Aug 15;74(4):566-78. Epub 2007 May 29. |
7(0,0,0,7) | Details |
| 18804253 | Wang JH, Wells C, Wu L: Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells. Virology. 2008 Nov 10;381(1):143-54. Epub 2008 Sep 18. |
5(0,0,0,5) | Details |
| 19409721 | Banerjee S, Guha SK: RISUG: a potential candidate for the entry inhibitor group of antiretroviral drugs. Med Hypotheses. 2009 Aug;73(2):150-2. Epub 2009 May 5. The proposed mechanism of action involves (i) interaction with gp120 and thereby preventing binding to CD4 and (ii) competitive binding with the viral glycoprotein and inhibit the glycoprotein - cell surface glyocosaminoglycan (HS) interaction. |
1(0,0,0,1) | Details |